GAVI Offers Up To $27.5M In Matching Funds To Support Malaria Vaccine Research

Reuters: GAVI alliance offers matched funds for GSK malaria vaccine pilot
“The GAVI global vaccine alliance has offered funding of up to $27.5 million for pilot tests of GlaxoSmithKline’s first-generation malaria vaccine, but only if other organizations promise to match that commitment…” (Kelland, 6/23).